DNLI
Price
$19.59
Change
+$0.49 (+2.57%)
Updated
Jan 13 closing price
Capitalization
2.82B
48 days until earnings call
INZY
Price
$1.72
Change
-$0.28 (-14.00%)
Updated
Jan 13 closing price
Capitalization
110.49M
65 days until earnings call
Ad is loading...

DNLI vs INZY

Header iconDNLI vs INZY Comparison
Open Charts DNLI vs INZYBanner chart's image
Denali Therapeutics
Price$19.59
Change+$0.49 (+2.57%)
Volume$840.47K
Capitalization2.82B
Inozyme Pharma
Price$1.72
Change-$0.28 (-14.00%)
Volume$1.52M
Capitalization110.49M
DNLI vs INZY Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. INZY commentary
Jan 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and INZY is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 14, 2025
Stock price -- (DNLI: $19.59 vs. INZY: $1.72)
Brand notoriety: DNLI and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 87% vs. INZY: 210%
Market capitalization -- DNLI: $2.82B vs. INZY: $110.49M
DNLI [@Biotechnology] is valued at $2.82B. INZY’s [@Biotechnology] market capitalization is $110.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.53B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, INZY is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 6 TA indicator(s) are bullish while INZY’s TA Score has 1 bullish TA indicator(s).

  • DNLI’s TA Score: 6 bullish, 2 bearish.
  • INZY’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than INZY.

Price Growth

DNLI (@Biotechnology) experienced а -1.16% price change this week, while INZY (@Biotechnology) price change was -40.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.85%. For the same industry, the average monthly price growth was -0.15%, and the average quarterly price growth was -4.30%.

Reported Earning Dates

DNLI is expected to report earnings on May 13, 2025.

INZY is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-5.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.82B) has a higher market cap than INZY($110M). DNLI YTD gains are higher at: -3.876 vs. INZY (-37.906). INZY has higher annual earnings (EBITDA): -90.3M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. INZY (132M). INZY has less debt than DNLI: INZY (46.8M) vs DNLI (52.5M). DNLI (0) and INZY (0) have equivalent revenues.
DNLIINZYDNLI / INZY
Capitalization2.82B110M2,563%
EBITDA-496.05M-90.3M549%
Gain YTD-3.876-37.90610%
P/E RatioN/AN/A-
Revenue00-
Total Cash837M132M634%
Total Debt52.5M46.8M112%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIINZY
RSI
ODDS (%)
Bullish Trend 6 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
81%
N/A
Momentum
ODDS (%)
Bullish Trend 6 days ago
80%
Bearish Trend 6 days ago
88%
MACD
ODDS (%)
Bullish Trend 6 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
85%
Bullish Trend 6 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 15 days ago
78%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGDDY15.72-0.07
-0.44%
CIE GENERALE DES ETABLISSEMENTS MICHELIN SA CLERMONT-FERRAND
CCOEY10.44-0.06
-0.57%
Capcom Co. Ltd
ZURVY28.72-0.33
-1.14%
Zurich Insurance Group Ltd
CRLFF4.69-0.06
-1.26%
Cardinal Energy Ltd.
NHHHF0.02N/A
-3.33%
FUELPOSITIVE CORP.

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-13.78%
IGMS - INZY
53%
Loosely correlated
-15.07%
BEAM - INZY
50%
Loosely correlated
-3.22%
NTLA - INZY
49%
Loosely correlated
-1.47%
DNLI - INZY
48%
Loosely correlated
+2.57%
NAUT - INZY
47%
Loosely correlated
+4.55%
More